Heightened expression of both Myc and Bcl-2 is a highly potent combination (highest in MZCD9+) promoting survival during Myc-driven proliferation and frequently occurs in various B-cell lymphomas (73, 74). Here, BCL2 is linked to B-cell non-Hodgkin lymphoma.